Status:

COMPLETED

Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Myeloproliferative Neoplasm

Eligibility:

All Genders

18+ years

Brief Summary

Myeloproliferative neoplasms (MPN) are hematological malignancies associated with a major risk of thrombosis. Monocytes are hematopoietic cells with a central role in thrombosis. An activation of mono...

Detailed Description

Myeloproliferative Neoplasms (MPN) are hematological malignancies characterized by an increased risk of thrombosis, in particular in Polycythemia Vera (PV) and Essential Thrombocythemia (ET). Predicti...

Eligibility Criteria

Inclusion

  • Adults patients (age ≥ 18 years)
  • Inclusion at diagnosis or during the year following the diagnosis of PV or ET (2016 WHO criteria except bone marrow biopsy that is optional in the presence of a marker of clonality)
  • Subject registered with a social security scheme
  • Written informed consent obtained

Exclusion

  • Patients with cytoreductive treatment (hydroxyurea, anagrelide, interferon, ruxolitinib) at the time of blood sampling
  • Chronic inflammatory disease (cancer, vasculitis, rheumatism, hepato-gastro-intestinal diseases).
  • Long term anti-inflammatory treatments:
  • Corticoids
  • Nonsteroidal anti-inflammatory drugs
  • Aspirin (\> 325 mg per day)
  • Cyclo-oxygenase II inhibitors
  • Persons under judicial safeguards, trustee or curatorship
  • Person unable to give her consent
  • Non-cooperative person
  • Exclusion period after another clinical study or participation to another clinical study in the 30 days before inclusion

Key Trial Info

Start Date :

October 5 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 22 2025

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT05419648

Start Date

October 5 2022

End Date

July 22 2025

Last Update

July 30 2025

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

CHU de Bordeaux, Hématologie clinique et thérapie cellulaire

Bordeaux, France

2

CHU de Bordeaux, Laboratoire Hématologie

Bordeaux, France

3

CHU de Bordeaux, Médecine interne et immunologie clinique

Bordeaux, France

4

CHU de Bordeaux, Médecine Interne et maladies infectieuses

Bordeaux, France